Much ado in the world of Lyme vaccine developmentThree different approaches in the pipeline. Face mask use reduces SARS-CoV-2 transmission in community settingsUse of face masks in the community will be an important component of an effective response to any future respiratory threats. Polypharmacy rising among seniors with heart failure Quebecers aged 65 and over with heart failure are taking more and more different pharmacological treatments, according to a new study Connecting the dots between distraction and neurodegenerative diseases Researchers at Laval University are studying our propensity for distraction in a bid to find ways to slow the progression of certain diseases. U.S. FDA approves new version of diabetes drug Mounjaro for weight loss Zepbound is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. ChatGPT: an ally in dealing with vaccine hesitancy AI chatbot scores in answering the 50 most frequently asked questions about COVID-19 vaccinations. Vaccine paves the way for new treatments for allergies A Franco-Quebec company is currently testing a vaccine that could treat human cat allergy and other common allergies in the future. Alberta government report on safe consumption ‘pseudoscience,’ says medical journal It says the United Conservative-commissioned report is biased in three major ways, all of which distort its findings against such sites. Ontario to add provincial tax to vaping products; meant to discourage youth uptake The combined tax would see manufacturers and importers paying $2 per two millilitres of vaping liquids for the first 10 millilitres, then $2 per 10 millilitres for volumes beyond that. CPAP use may reduce secondary CVD events As long as people use the devices at least four hours per day. First Previous 43 44 45 46 47 Next Last
